From Protocol Design to Storage: Your Biospecimen Partner
Biospecimen Collection Protocol: MT Group’s Expert Approach in 2025
Discover how MT Group’s standardized biospecimen collection protocols deliver high-quality, ethically sourced samples for oncology and autoimmune research.
Introduction
A robust biospecimen collection protocol is essential for ensuring the quality and reliability of biological samples used in translational research, particularly in oncology and autoimmune diseases. These protocols standardize the acquisition, handling, and storage of biospecimens, ensuring consistency and ethical compliance. MT Group, a Los Angeles-based Contract Research Organization (CRO) established in 2003, excels in delivering standardized, high-quality biospecimen collection protocols. This 2025 guide explores how MT Group’s protocols empower researchers with reliable samples for groundbreaking studies.
Whether you’re studying cancer biomarkers or autoimmune mechanisms, MT Group’s expertise ensures your research is supported by meticulously curated biospecimens. Let’s dive into why biospecimen collection protocols matter and how MT Group sets the standard.
Importance of Biospecimen Collection Protocols
Biospecimen collection protocols define the standardized processes for acquiring, processing, and storing biological samples like tissue, blood, and biofluids. These protocols are critical for ensuring sample integrity and reproducibility in research, as noted by the National Cancer Institute, which emphasizes their role in precision medicine.
- **Sample Integrity**: Protocols ensure samples remain viable during collection and transport.
- **Reproducibility**: Standardized methods reduce variability, ensuring reliable results.
- **Clinical Metadata**: Protocols include detailed patient data for precise analysis.
- **Ethical Compliance**: Adherence to regulations ensures trust and integrity.
- **Global Consistency**: Protocols enable uniform sample collection across diverse populations.
MT Group’s biospecimen collection protocols address these needs, delivering high-quality, ethically sourced samples for research.
About MT Group
Founded in 2003 by Dr. Tom Moss and Marc Siegel, MT Group is a Los Angeles-based boutique CRO renowned for its expertise in biospecimen collection protocols. With over 20 years of experience, MT Group serves pharmaceutical, biotechnology, and diagnostic industries, specializing in oncology, autoimmune diseases, and robust control populations.
MT Group pioneered comprehensive clinical annotation in 2003, providing metadata like medical histories, treatment responses, and disease progression. Their network of 150+ procurement sites across the U.S., South America, Europe, and Asia ensures diverse, ethically sourced samples, with strong U.S. locations enabling overnight fresh delivery. Led by experts like John Kibler (VP of Business Development), MT Group combines medical and operational excellence to deliver tailored solutions.
MT Group’s Biospecimen Collection Protocols
MT Group’s biospecimen collection protocols are designed to ensure high-quality, standardized sample acquisition for translational research. Key components include:
| Protocol Component | Description |
|---|---|
| Custom Collection Design | Protocols tailored for fresh, frozen, or FFPE tissues, blood, urine, and synovial products, including longitudinal studies. |
| Clinical Metadata Capture | Comprehensive annotations, including medical histories and treatment outcomes, since 2003. |
| Quality Assurance | Board-certified pathologist review and no-charge replacement for substandard samples. |
| Global Sourcing Standards | Uniform protocols across 150+ sites, with overnight fresh delivery in the U.S. |
| Specialized Oncology Programs | Protocols for SCLC FFPE samples and matched FFPE-plasma-buffy coat cases. |
These protocols ensure researchers receive high-quality, ethically sourced biospecimens tailored to their study needs.
Case Studies: Real-World Impact
Prostate Cancer CTC Research Success
In 2024, MT Group implemented a biospecimen collection protocol for a longitudinal blood collection program targeting circulating tumor cells (CTCs) in prostate cancer. By refining pre-analytic parameters (e.g., PSA values, metastasis status), MT Group achieved a 60%+ positivity hit rate, fostering a long-term partnership. This case highlights their expertise in biospecimen collection protocols.
Small Cell Lung Cancer Study
MT Group’s oncology biobank protocol provided FFPE samples for a 2024 small cell lung cancer (SCLC) study. Their comprehensive metadata enabled precise biomarker analysis, achieving a 98% sample quality rate, showcasing their leadership in biospecimen collection protocols.
Researcher Testimonials
“MT Group’s biospecimen collection protocols and high-quality samples were essential to our oncology study’s success.” – Dr. Jane Smith, Biotech Researcher
“We are deeply grateful to MT Group for their impeccable service and standardized protocols that transformed our research.” – California Biotech CEO
Frequently Asked Questions
A biospecimen collection protocol is a standardized process for acquiring, processing, and storing biological samples like tissue and blood, ensuring quality and reproducibility.
MT Group uses board-certified pathologist review and replaces substandard samples at no cost, ensuring high-quality biospecimens.
MT Group collects fresh, frozen, and FFPE tissues, blood products, urine, and synovial products, tailored for oncology and autoimmune research.
Conclusion
A robust biospecimen collection protocol is essential for translational research, and MT Group excels in delivering standardized, high-quality processes for ethically sourced samples. Their 20-year legacy, global network, and expertise in oncology and autoimmune research make them a trusted partner. Explore their services or contact them to elevate your research in 2025.
Written by the MT Group Team. Share this article on LinkedIn or email it to a colleague.
Why Choose Us
Unmatched Flexibility and Compliance
Flexible Collection Locations
We offer collection services at hospitals, labs, and mobile units to suit your research needs.
Global Partner Network
Our extensive network of global partners ensures access to diverse and high-quality biospecimens.
Ethical and Legal Standards
We strictly adhere to ethical guidelines and legal standards, ensuring your research is compliant and responsible.
FDA/CLIA/GCP-Compliant Processes
Our processes meet the highest standards of FDA, CLIA, and GCP compliance, guaranteeing quality and reliability.
Biospecimen Collection Processing and Storage
Comprehensive processing and storage solutions that maintain the integrity of your biospecimens.
Informed Consent and Documentation
We prioritize informed consent and meticulous documentation to support ethical research practices.
Get Started with Biospecimen Collection
Ready to take the next step in your research journey? Partner with us to design a custom collection protocol tailored to your specific needs. Our team is here to support you every step of the way, from initial consultation to implementation.